HemoCleanse dialysis subsidiary merges with SORB
This article was originally published in Clinica
Executive Summary
HemoCleanse subsidiary RenalSolutions has signed a binding letter of intent to merge with SORB Technology, making SORB a division of West Lafayette, Indiana-based RenalSolutions. RenalSolutions is a wholly owned subsidiary of HemoCleanse, a privately owned company which has five subsidiaries, concentrating on liver and kidney-related chronic conditions as well as cancer and infectious disease.
You may also be interested in...
Impella Safety Update: Data Supports Pump For Qualified Patients
Updated data from a postmarket study of Abiomed’s Impella RP right-heart pump further supports the device’s safety for a specific patient population.
Quality, Safety, MDSAP A Focus For Medtech In New USMCA Trade Agreement
The new US-Mexico-Canada (USMCA) trade agreement includes language on enhancing regulatory compatibility between the three countries by recognizing quality systems audits performed under the Medical Device Single Audit Program (MDSAP). It also stipulates that each trading partner “consider its resources and technical capacity” in ensuring the safety, effectiveness and quality of devices – and more. Medtech industry advocacy group AdvaMed is praising the deal, reached by the three countries on 10 December.
Novo Nordisk Targets Smart Insulin, Stem Cell-Therapies
Novo Nordisk’s CEO talks to Scrip about the promise of glucose-responsive insulin, stem cell therapy, and a diabetes landscape without Sanofi.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: